Canabidiol e psiquiatria - existe alguma evidência científica?

Marcelo Allevato; Angelo Americo Martinez Campana

doi:10.25118/issn.2965-1832.2022.550

Authors

Marcelo Allevato Médico Psiquiatra (ABP/CFM), Mestre em Psiquiatria (IPUB/UFRJ), Membro Titular da Associação Brasileira de Psiquiatria (ABP), International Fellow of the American Psychiatric Association (APA) https://orcid.org/0000-0002-5231-7187
Angelo Americo Martinez Campana Médico psiquiatra associado efetivo da ABP, especialista pela UFRGS. Conselheiro da Associação Brasileira de Estudos do Álcool e outras Drogas - ABEAD. Diretor administrativo da Villa Janus-Porto Alegre

DOI:

https://doi.org/10.25118/issn.2965-1832.2022.550

Keywords:

cannabidiol, psychiatry, scientific evidence, psychiatric illnesses, evidence-based medicine

Abstract

There is currently a lot of publicity, without scientific evidence, about the use of cannabidiol and other components of Cannabis for the treatment of psychiatric illnesses. The Federal Council of Medicine - CFM authorizes the compassionate use of cannabidiol only for cases of children and adolescents with difficult-to-treat epilepsy, that is, cases in which conventional options do not work. On today's ABP TV we will receive psychiatrists specializing in chemical dependency to answer: Cannabidiol and psychiatry - is there any scientific evidence?